Your partner for preclinical drug discovery and developtment
Pharmacelsus, Germany´s market-leading early stage CRO, plans, organizes and realizes customized preclinical studies for more than 20 years. Our assays meet national and international regulatory demands while using our unique consultative approach to serve more than 120+ satisfied customers who rely on our expertise, experience and passion for science.
Hit-to-Lead and Lead Optimization
The Pharmacelsus portfolio covers the complete drug discovery and development testing program for small molecules and peptides in vitro, in vivo, ex vivo as well as G(C)LP and non-GLP bioanalysis. Structural, physicochemical and functional characterization of Biopharmaceuticals (e.g. Antibodies, ADCs, etc.) complements our comprehensive portfolio.
Preclinical and clinical services CRO
The experienced and highly committed Pharmacelsus team offers a variety of different services the following in Areas.
Your contact at Pharmacelsus
MUDr. Maria Li
Director Business Development
Mobile: +49 173 889 4288
GBA Group Pharma Sites
Pharmacelsus - Präklinische Dienstleistungen
Science Park 2